GAVI signs 200 m COVID-19 vaccine supply deal with J&J

Monday, 24 May 2021 00:22 - - {{hitsCtrl.values.hits}}

GENEVA (Reuters): The GAVI Vaccine Alliance has signed an advanced purchase agreement with Johnson & Johnson for 200 million doses of its COVID-19 vaccine for the COVAX vaccine-sharing program, it said in a statement on Friday.

GAVI said the goal was to have the doses available in 2021 and for both self-financing participants of COVAX as well as poorer countries.

“As a one dose vaccine, the J&J vaccine has particular relevance for places with difficult infrastructure, making it a very important addition to the portfolio,” said GAVI CEO Seth Berkley.